The Fast Money traders take a look at today's biggest market movers.» Read More
Talk about poking a hornet's nest: Nothing generates more reader feedback than a post about Apple. Mix in some Steve Jobs, speculation, rumors, a dash of innuendo, and bingo, you've got yourself a kind of magic eyeball catcher!
Leerink Swann, which specializes in healthcare equities research, is out with a couple of noteworthy surveys--one on the collateral damage to Merck and Schering-Plough's Vytorin this week and the other on drug-coated stents from Abbott Labs, Boston Scientific, Johnson & Johnson and Medtronic.
In the last three weeks, the message has been coming from a variety of sources, but it's generally been the same: forget about the auto industry rebounding anytime soon. In fact, some are saying things may get worse before they get better.
The CEO explains why his underpromise-overdeliver strategy keeps surprising Wall Street.
Wachovia, which on Tuesday posted a record $8.86 billion second-quarter loss, said Chief Financial Officer Thomas Wurtz plans to leave the fourth-largest U.S. bank after a successor is named.
Microsoft will announce plans to expand its relationship with online social network Facebook to provide web search and search advertising, a source familiar with the matter said on Thursday.
On Squawk Box this morning, CEOs from various industries aired their insights on the economy, energy prices, real estate and politics.
So, yesterday I posited a theory that the weak American economy might be hurting sales growth of erectile dysfunction drugs. I wondered whether men might be cutting their pills in half and/or not filling their expensive prescriptions if they're having to tighten their belts.
But not Cramer. He says this restaurant is on the rise.
The company holds to its 2008 outlook, despite a drop in second-quarter earnings. and says it is will continue to look at possible transactions, says CEO Jerry Yang.
Foreign companies are buying American companies and the CEO of Home Depot comments on the economy. Following are today's top videos:
Online brokerage Charles Schwab said Tuesday that founder Charles Schwab would step down as chief executive in October, and will be replaced by Walter W. Bettinger.
Recently I blogged about Merck advertising its cervical cancer vaccine Gardasil to a captive audience during trailers for the "Sex and the City" movie.
Verizon Communications Chief Executive Ivan Seidenberg said its Verizon Wireless venture should complete its acquisition of rural mobile phone service provider Alltel by the of the year.
CNBC asked the smartest people in the room for their thoughts on the markets and the economy.
The buyout offer from Swiss drug giant Roche has shares of DNA trading at their highest level in about two-and-a-half years and according to CNBC stock-stat maven, Robert Hum, if they close up at least 8.88% it'll be their biggest one-day percentage gain since April 15, 2005.
It may be the number one question I get from people when they ask about the struggling U.S. automakers: Who would want these guys if they ever go belly up or get sold?
arr's Chairman and CEO Bruce Downey told me Teva's CEO Schlomo Yanai made the first move. But it didn't happen in a long-distance phone call from Tel Aviv to New Jersey. They say they were at an industry conference in Palm Beach outside some burger joint when the subject came up.
The stock is down on lowered guidance, but Wall Street's got it all wrong, the chief executive says.
Computer chip maker Advanced Micro Devices said Thursday that Chief Executive Hector Ruiz was stepping down to be replaced by President and Chief Operating Officer Dirk Meyer, effective immediately.